Company
United StatesPublic company, NYSE: DALDelta Air Lines, Inc (NYSE: DAL), Melbourne, FL – FDA Inspections
Inspection records and compliance data for Delta Air Lines, Inc in Melbourne, Florida. 6 FDA inspections on record, last inspected November 10, 2025. Publicly traded as NYSE: DAL.
Company Profile
This profile covers Delta Air Lines, Inc based in Melbourne, Florida, United States.
FDA Inspection History
- FDA inspections
- 6
- OAI
- 0
- VAI
- 0
- NAI
- 0
- Unclassified
- 6
- Form 483s
- 0
- Warning letters
- 0
First inspected October 8, 2025. Last inspected November 10, 2025.
FDA inspections (6)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| November 10, 2025 | Not classified | Foods & Cosmetics | 1291310 |
| November 10, 2025 | Not classified | Foods & Cosmetics | 1291198 |
| October 23, 2025 | Not classified | Foods & Cosmetics | 1289162 |
| October 23, 2025 | Not classified | Foods & Cosmetics | 1289038 |
| October 8, 2025 | Not classified | Foods & Cosmetics | 1287040 |
| October 8, 2025 | Not classified | Foods & Cosmetics | 1286928 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Delta Air Lines, Inc
Stock ticker
DAL
Exchange
NYSE
Share price
$85.55
Market cap
$56.3B
Price as of
November 6, 2026
FEI Number
3040646641
Address
Melbourne, Florida 32901, United States
Country
United States
ID: 02deee92-eb36-4fa8-8b76-0f175254ed47